Session Highlights

Get ready for an exciting paediatric infectious diseases scientific programme in Athens. The committee is working hard to ensure you get to learn from the best international speakers on the latest topics you need to know about.

Plenary Symposia


  • Emergence and Management of the COVID-19 Pandemic: Lessons Learned – Kate O’Brien (USA)
  • Mathematical Modelling and Pandemic Response – John Edmunds (UK)


  • Vaccines Against COVID-19: The Way Forward – Paul Offit (USA)
  • Lessons Learned from Vaccine Clinical Trials and Post-Licensing Implementation – Andrew Pollard (UK)


  • Progress Towards A Universal Influenza Vaccine – Kathryn Edwards (USA)
  • The CRISPR‑Cas System: Biological Function in Microbes and Applications in Infectious Diseases – Nektarios Tavernarakis (Greece)


After the amazing feedback from this session at ESPID 2021, we’ll be inviting leaders in the ESPID community to once again share with us some “Forgotten Wisdom”.

  • Steve Black (USA)
  • Karina Butler (Ireland)
  • Susanna Esposito (Italy)
  • David Greenberg (Israel)
  • Ulrich Heininger (Switzerland)
  • George Syrogiannopoulos (Greece)


  • Climate and Environmental Change and Emerging Infectious Diseases – Jan Semenza (Sweden)
  • Emerging and Re-Emerging Viral Infections in Europe – Anna Papa (Greece)
  • Dinosaur Extinction, Mammalian Emergence and Fungal Diseases – What is The Connection? – Arturo Casadevall (USA)


  • WHO Antibiotic Guidance and Global Policy – What Next? – Michael Sharland (UK)
  • New and Old Gram Negative Antibiotics for Children – What’s in the Pipeline? – William Hope (UK)

Parallel Symposia

  • COVID-19 in Children
  • Infections in Children – Prevention is Best
  • Infections in Immunocompromised Hosts
  • Paediatric Tuberculosis Treatment
  • Management of Fever
  • Microbiome in Health and Disease
  • Precision Vaccinology
  • Fungal infections in Paediatrics
  • Artificial Intelligence in Paediatric Diagnosis


  • Congenital Infections
  • Antibiotic Stewardship

Delve into Introductions to Sessions

Joint Symposia with Leading Societies

Molecular Microbiology has obtained a very significant position in the diagnosis and management of infectious diseases across all ages today. This joint symposium with the European Society of Clinical Microbiology and Infectious Diseases will focus on two important aspects of the contemporary role of the Microbiology Laboratory: a) the role that the whole genome sequencing plays in the precise diagnosis and optimal management of serious infectious diseases in patients, including neonates and children, and b) how the Micro Lab contributes in the antibiotic stewardship of the neonatal and pediatric unit by its precise and early diagnostic approach.

  • New Diagnostic Tools in Molecular Microbiology: Which May Impact the Diagnosis of Infections in Children?
    Mario Poljak (Slovenia)
  • Impact of NGS in The Diagnosis and Management of Infectious Diseases
  • How to Implement New Diagnostic Tools in the Micro Lab: The Diagnostic Stewardship Approach
    Maurizio Sanguinetti (Italy)
  • Live Q&A

Host–pathogen interaction is considered a highly dynamic process between diverse microbial pathogens and hosts in all stages of pathogenic infection, from invasion to dissemination. This interaction is vital to our understanding of infectious disease, as well as its treatment and prevention and there are some recent fascinating advances in this era. The presentations in this session will guide the audience through the infectious complications as well as new diagnostics of New Inborn Errors of Immunity and will also summarize the evidence of the literature on type I Interferon defects in COVID-19 infections. Join ESPID and ESID, the European Society of Immunodeficiencies for:

  • Type I Iterferon Defects in COVID-19
    Paul Bastard (France)
  • Infectious Complications of New Inborn Errors of Immunity
    Isabelle Meyts (Belgium)
  • New Diagnostics for Inborn Errors of Immunity
    Alain Fischer (France)
  • Live Q&A

The role of the microbiome in the pathogenesis of inflammatory bowel disease is increasingly investigated and  now we know that the microbiota has a considerable role in IBD and that exploring the  interactions between intestinal microorganisms and the host may reveal new horizons to prevent and treat the disease. The prevalence of chronic hepatitis C is lower in children than adults, however millions of children worldwide have chronic HCV infection. Newer antiviral regimens have now been developed, although much remains to be elucidated regarding age of treatment initiation and treatment choice for particular HCV genotypes. Join ESPID and The European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) for:

  • Paediatric IBD and the Role of the Microbiome
    Johan Van Limbergen (Netherlands)
  • Hepatitis C in Children: Update on Management
    Giuseppe Indolfi (Italy)
  • Live Q&A

Epidemiological data indicate that SARS-CoV-2 is the trigger for MIS-C, a rare but potentially severe hyperinflammatory condition. The presentations in this session will guide the audience through the challenges of diagnosis and treatment and the opportunities to address unresolved questions about MIS-C including genetic contributors, pathophysiology and mid- or long-term adverse outcomes. Join ESPID and PIDS, the Pediatric Infectious Diseases Society for:

  • Michael Levin (United Kingdom)
  • Adriana H. Tremoulet (United States of America)
  • Live Q&A
Register Now Book Hotel Subscribe